Loading
·
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.